Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116 (Q42873323)
Jump to navigation
Jump to search
scientific article published on November 1, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116 |
scientific article published on November 1, 2010 |
Statements
1 reference
Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116 (English)
Xiaochun Li
1 reference
Wael Harb
1 reference
Daniel Bradford
1 reference
Jose Bufill
1 reference
Sreenivasa Nattam
1 reference
Jyoti Patel
1 reference
William Fisher
1 reference
Jingwei Wu
1 reference
Nasser Hanna
1 reference
Erin M. Casey
1 November 2010
1 reference
1 reference
5
1 reference
11
1 reference
1815-1820
1 reference
1 reference
Identifiers
1 reference
1 reference